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Researchers explore connection between 
cholesterol and colon-tumor cells 
Cholesterol-lowering drugs, such as lovastatin, may be effective 
in halting the spread of colon cancer to the liver, according to a 
recent BUSM study. BUSM researchers found that human 
colon-tumor cells deprived of cholesterol lacked the ability to 
generate LDL receptors to draw LDL cholesterol—needed for 
the tumor cells to grow—directly into the cells. 
All normal cells need cholesterol, which they obtain by 
manufacturing it or by extracting it from the blood serum. Pre-
vious studies in animals demonstrated that tumor cells deprived 
of cholesterol generated receptors to extract cholesterol from 
blood serum, and that these cells took up more cholesterol than 
normal cells because of their rapid proliferation. 
The BUSM researchers studied human colon-tumor cell lines 
in vitro to determine if, when deprived of cholesterol, they also 
had the ability to generate LDL receptors. Instead, the re-
searchers found that five out of the six human colon-tumor cells 
they studied did not produce LDL receptors. 
Selwyn Broitman, Ph.D., FACG, a professor of pathology at 
BUSM and the senior researcher on the project, and Michelle 
Fabricant, Ph.D., a former graduate student at BUSM and the 
lead author of the study, say this research may evenmally help 
patients with liver metastases. "It's possible that we can halt the 
spread of these tumors into the liver or kill them by using 
cholesterol-lowering drugs," says Broitman. "Cholesterol-lower-
ing drugs may be useful in conjunction with chemotherapy or as 
a preventive measure when colon tumors are surgically 
removed." 
Controlled delivery of medication 
for Parkinson's proves effective 
Controlled-release (CR) Sinemet—a new form of delivery of 
levodopa (LDOPA)—is now available to treat patients with 
Parkinson's disease. Sinemet is a combination of LDOPA, the 
most effective treatment of Parkinson's, and carbidopa. A 
recent BUSM study, published in Neurology, demonstrated that 
two daily doses of Sinemet CR were as effective in controlling 
Parkinson's symptoms as four daily doses of standard Sinemet. 
Parkinson's disease is a neurological condition that usually 
strikes those over the age of 60, causing such symptoms as 
tremors, body rigidity and speech and facial disturbances. Its 
cause is unknown. Although patients may experience changes 
in motor function when the medication "kicks in" or "wears off," 
those changes are somewhat predictable. Over time, however, 
the effectiveness of medication declines, and patients who have 
been taking standard Sinemet for years may experience random 
swings in motor function. 
This study suggests that, in addition to the advantage of 
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having to take fewer daily doses, Sinemet CR produces a more 
stable level of the drug in patients' blood, resulting in less 
dramatic variations in motor function. "The effects of Sinemet 
CR are longer lasting," says Robert G. Feldman, M.D., the chair-
man of the Department of Neurology and the principal inves-
tigator of the study. "Patients are better able to predict when 
they will be most functional." 
Feldman says the convenience of Sinemet CR may make it 
easier for patients to comply with their treatment program. He 
adds that the longer-lasting drug may help Parkinsonian patients 
with two frequently reported problems: an inability to sleep 
through the night and fatigue. 
Study provides first data validating 
visual skin cancer screenings 
A new BUSM study shows that melanoma/skin-cancer screen-
ings are as effective as other major cancer-screening efforts, 
such as mammography for breast cancer and pap smears for cer-
vical cancer. Published in the current issue of Cancer, this 
study—the first systematic statewide follow-up of people who 
had suspected cancer—also provides the first data that validate 
the visual exam as an appropriate cancer-screening tool. 
Researchers from the Schools of Medicine and Public Health 
collected data from all 14 Massachusetts sites that participated in 
the first statewide screenings in 1986 and 1987 sponsored by the 
American Academy of Dermatology. Of the 2,560 people ex-
amined, 31 percent were thought to have abnormal screens and 
were advised to see their physicians or dermatologists for addi-
tional evaluation. At the time of the screening, dermatologists 
listed the worst single diagnosis suspected. 
Howard Koh, M.D., an associate professor of dermatology. 
2 
medicine and public health, and other researchers followed up 
on the 459 screenees suspected of having melanoma, non-
melanoma skin cancer, dysplastic nevi and congenital nevi. 
Follow-up information was gathered on 63 percent of the 459 
screenees; the remaining 37 percent either did not seek follow-
up care or did not respond to inquiries. 
Of these screenees, 142 were diagnosed with lesions, consist-
ing of 9 cases of melanomas, 91 cases of non-melanoma skin 
cancers, 39 dysplastic nevi and three congenital nevi. Of these, 
100 (70 percent) were pathologically confirmed through biopsy. 
Although most dermatologists believe that a visual exam can 
accurately detect melanoma/skin cancer, until now there had 
been a lack of data to confirm this viewpoint. "This study has 
shown that a visual examination by a dermatologist is an ap-
propriate cancer-screening tool and compares favorably with 
other cancer-screening tests, such as mammograms and pap 
smears," said Koh. 
Researcher receives grant from 
Robert Wood Johnson Foundation 
Michael T. Watkins, M.D., an assistant professor of surgery and 
pathology, recently was awarded a $157,625 grant from the 
Robert Wood Johnson Foundation to continue his research on 
the effects of ischemia—decreased blood flow and oxygen supp-
ly—on the arterial wall. Watkins, a researcher at the Mallory In-
stitute of Pathology, is studying ischemic injury on the cellular 
level in order to prevent loss of limb or los& of Umb function^due 
to hardening of the arteries. Watkins's advisor for the grant is 
Christian C. Haudenschild, M.D., a professor of pathology. 
The Robert Wood Johnson Foundation's Minority Medical 
Development Program offers four-year, postdoctoral research 
grants to support minority physicians committed to careers in 
academic medicine and biomedical research. 
'Jittery' newborns may be more 
difficult to care for, study shows 
Jittery newborns are likely to be less attentive and more difficult 
to console than non-jittery newborns and, therefore, may pose 
special caretaking problems for parents, according to a recent 
BUSM study published in Pediatrics. Although jittery behavior 
is common in healthy full-term newborns, its significance has 
been unclear. 
Researchers from the Division of Developmental and Be-
havioral Pediatrics at Boston City Hospital and BUSM who con-
ducted the study found that jitteriness may indicate that a 
newborn is neurologically more disorganized than a non-jittery 
newborn. Steven Parker, M.D., the principal investigator of the 
study and an assistant professor of pediatrics, suggests that 
pediatricians who identify a newborn's jitteriness carefully 
evaluate other aspects of the infant's behavior, especially his or 
her visual attentiveness and ease of consolability. 
"A pediatrician who recognizes jitteriness and its imphca-
tions can play an important role in guiding parents' responses to 
their infants and in helping them develop a positive early 
relationship with their child," Parker says. 
In their evaluation of 936 healthy infants bom to women 
receiving prenatal care at the Women and Adolescent Prenatal 
Clinics at BCH, the researchers also assessed the clinical sig-
nificance of jitteriness in relation to mothers' use of cigarettes, 
alcohol, marijuana and cocaine. Although no association was 
found between jitteriness and cigarette or alcohol use, Parker 
says there was only a slight increase of jittery behavior in infants 
exposed to marijuana and cocaine. 
Aging sbown to significantly reduce 
body's ability to produce vitamin D3 
The ability of the body to produce vitamin D 3 — a n essential fac-
tor in calcium and bone metabolism—decreases with age, a 
recent study shows. This finding, published in The Lancet, may 
have clinical significance for people over the age of 60 who are 
already prone to vitamin D deficiency, and who are at an in-
creased risk for hip, wrist and spinal fractures. 
Michael Holick, Ph.D., M.D., the director of the Vitamin D, 
Skin and Bone Research Laboratory at BUSM, conducted a 
study with Lois Matsuoka, M.D., from the Medical College of 
Thomas Jefferson University, that compared six healthy white 
subjects aged 20 to 30 with six healthy white subjects aged 62 to 
80. Both groups received equal amounts of simulated sunlight. 
In the younger group, there was a 10- to 20-fold increase in the 
e leva t ion^ vitamin DjJn theJjloodv The older participants had 
only a 1- to 5-fold increase. According to Holick, this reduction 
can not be explained by the decrease in total mass of the skin. 
Holick's previous work with vitamin D has shown that casual 
exposure to sunlight is useful in the production of vitamin D, 
especially for the elderly. However, depending on weather and 
latitude during the winter months, ultraviolet radiation may not 
be sufficient for vitamin D synthesis to occur. 
"The combination of the body's decreased ability to produce 
vitamin D as it ages and the lack of sufficient sunlight during 
winter and early spring, make the elderly even more prone to 
vitamin D deficiency and its risks," says Holick. 
Holick recommends that people over the age of 60 who do 
not receive sufficient sources of dietary vitamin D, expose then-
hands, face and arms to sunlight 15 minutes a day three times a 
week during sunny weather or supplement their diet with a multi-
vitamin that contains 400 international units of vitamin D. 
Medical students discuss current issues 
in medicine at conference 
Approximately 300 students from BUSM, Harvard Medical 
School and Tufts University School of Medicine recently at-
tended "Current Issues in Medicine: Vital Signs for Tomorrow," 
a winter workshop sponsored by the American Medical Students 
Association. Held at BUSM, the workshop addressed some of 
the issues in medicine that may not be covered in the classroom, 
such as providing healthcare to the homeless, preventing 
During "On Being a Physician and a Parent," one of the many 
seminars held during the AMSA's winter workshop, physicians 
discussed how they have combined careers in medicine with 
parenthood. Pictured, from left, are Marianne N. Prout, M.D., 
M.P.H., an associate professor of public health (epidemiology and 
biostatistics) and socio-medical sciences and community medicine; 
husband and wife. Randy Glidden, M.D., a practicing anes-
thesiologist, and Elaine Alpert, M.D., assistant dean for student 
affairs and an assistant professor of medicine; and Sheryl Birchette-
Pierce, M.D., a practicing internist. (Photo by David Keough, 
BUSM Educational Media Support Center) 
violence and educating youths about AIDS. "~ 
"This program may raise questions and pique interest in 
topics students never considered," said Andy Chiou, a second-
year BUSM student and director of the winter conference. "Stu-
dents may then want to get involved further in these areas and 
guide their medical careers to include them." 
The workshop concluded with a keynote address by Bemie 
Siegel, M.D., a well-known author and lecturer on positive think-
ing and cancer. 
Ophthalmology Dept. receives grant 
from Research to Prevent Blindness 
The Department of Ophthalmology at BUSM has been awarded 
a $45,000 grant from Research to Prevent Blindness for further 
research into the prevention and treatment of blinding eye dis-
eases. The funds will be used to support BUSM's ongoing re-
search into corneal disorders, uveitis and retinal degeneration. 
According to Howard Leibowitz, M.D., chairman of the Depart-
ment of Ophthalmology and chief of Ophthalmology at the 
University Hospital, each of these disorders is a major cause of 
blindness, yet little is known about how to prevent or treat them. 
BUSM's researchers are developing a synthetic cornea to 
completely replace a diseased cloudy cornea and are studying 
biological factors that will enhance healing and allow the syn-
thetic cornea to be supported permanently in the eye. Other re-
search efforts involve determining the cause of uveitis, and the 
means to prevent or treat various forms of uveitis. Currently the 
cause of uveitis—a disorder characterized by inflammation 
within the eye—is not known and no cure is available. 
Retinal degeneration adversely affects the nerves of the eye 
and interferes with patients' ability to see. Researchers are now 
able to maintain retinal nerve cells and retinal pigment epithelial 
cells (cells that provide nutrition and oxygen to the retinal nerve 
cells) in a living state outside the eye. Experimental smdies on 
these cells are providing information on what goes wrong in 
patients with retinal degeneration and offering hope that a means 
to treat these blinding disorders will be found. Additional data 
defining the effect of diabetes on retinal cells has evolved from 
these studies. 
RPB awards annual grants to 61 medical schools and is the 
world's leading voluntary organization in support of eye re-
search. Previous RPB grants and awards to BUSM total 
$313,000. 
Kaufman Lecture panel to feature 
discussion on health-care crisis 
The S. A. Kaufman, M.D., Memorial Lecture will feature a dis-
tinguished panel of participants in a discussion of "The Health 
Care Crisis: Strategies for Resolution." Panelists will include 
Arnold S. Relman, M.D., editor of th& New England Journal of 
Medicine, and Jerome H. Shapiro, M.D., president of the 
American College of Radiology and chairman of the radiology 
department at BUSM. The moderator will be Lester C. Thurow, 
dean of the Sloan School of Management, Massachusetts In-
stitute of Technology. 
The memorial lecture, co-sponsored by the Department of 
Radiology and the Sloan School of Management, will be held on 
April 3 at 6 p.m. in Bowen Hall—E51-329 at the Sloan School, 
50 Memorial Drive, Cambridge, Mass. A reception will follow. 
The family, friends and colleagues of the late Seymour A. 
Kaufman, M.D., a clinical professor of radiology for 14 years 
and an alumnus, established a memorial fund after his death in 
1984. The proceeds of this fund support the Memorial Lecture, 
which is presented each year by distinguished speakers in the 
field of medicine and allied disciplines. 
Faculty member presents paper 
at neuropsycbology conference 
Marlene Oscar Berman, Ph.D., director of the neuropsychology 
laboratory of the Department of Biobehavioral Sciences, recent-
ly presented "Experimental and Clinical Approaches to Varieties 
of Memory" at the New York Neuropsychology Group's 11th an-
nual conference. The conference, titled "Attention and Memory 
in Theory and Practice," was held as a joint meeting with the 
Psychology Section of the New York Academy of Sciences at 
the New York University Medical Center on March 10. 
Association seeks participants in project 
supporting animal researcb 
The incurably ill For Animal Research (iiFAR) has launched a 
nationwide petition drive to show support for animal research 
and is seeking involvement from organizations and individuals. 
The association plans to present the petition to selected members 
of Congress at a press conference this summer. Those persons 
interested in obtaining a copy of the petition should contact 
I 4 
Steve Carroll, executive director, iiFAR, P.O. Box 1873, 
Bridgeview, 111. 60455; (312) 598-7787. 
BCH seeks additional volunteers 
for children's reading program 
Reach Out And Read (ROAR), a volunteer reading program for 
children at Boston City Hospital, is seeking volunteers, par-
ticularly members of the community who speak Spanish or 
Haitian Creole. 
Exposure to books at an early age, even before a child can 
read, is important to a child's future success in learning to read, 
according to Robert Needlman, M.D., the co-director of ROAR, 
a pediatrician at BCH and a fellow in the Division of Develop-
mental and Behavioral Pediatrics at BUSM. "By sharing books 
with children, ROAR volunteers express a love of reading that 
can help shape a child's attitudes and perceptions. They learn 
that books are meant to be enjoyed, not avoided," says 
Needlman. He also points out that parents who see then-
children reacting enthusiastically to books are encouraged to 
read with their children. 
ROAR began a year ago as an initiative of the Child Develop-
ment Project, a unique collaboration between BCH pediatricians 
and Boston-area educators to identify and provide treatment for 
children with developmental problems. This year's funding is 
provided by the Francis R. Dewing Foundation, Ronald 
McDonald's Children's Charities and a Boston Globe grant 
awarded through the Reading is Fundamental program. In as-
sociation with the Boston Partners in Education, ROAR en-
courages community participation in helping Boston-area 
children succeed in learning, and in life. For information about -
becoming a ROAR volunteer, please contact Marilyn Rollins in 
the BCH Community Relations Office at 534-5122. 
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